Drug Screening Market Size 2023, Share, Business Growth, Report 2028
How Big is the Drug Screening Market?
IMARC Group's latest research report, titled “Drug Screening Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 ,” offers a comprehensive analysis of the industry, which comprises insights on the global drug screening industry. The global drug screening market size reached US$ 6.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.8 Billion by 2028, exhibiting a growth rate (CAGR) of 7.6% during 2023-2028.
What is Drug Screening?
Drug
screening refers to the process of testing individuals or biological samples
for the presence of specific drugs or their metabolites. It involves urine,
blood, saliva, hair, and sweat drug testing. It is conducted to detect and
monitor drug use, abuse, or adherence to prescribed medications. It helps
ensure public safety by identifying individuals under the influence of drugs,
reducing accidents, and preventing impaired driving. It promotes patient safety
by monitoring medication adherence and detecting potential substance abuse,
enabling timely intervention and treatment adjustments. It enhances workplace
safety by identifying employees who may pose a risk due to drug use, reducing
accidents, and maintaining a productive work environment.
Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/drug-screening-market/requestsample
What are the growth prospects and trends in the drug screening industry?
At present,
the increasing adoption of innovative drug screening technologies, such as
remote or at-home testing kits, to reduce the risk of virus transmission in
healthcare facilities and workplaces represents one of the crucial factors
impelling the growth of the market. Besides this, the rising awareness about
the detrimental effects of substance abuse on public health and safety is
strengthening the growth of the market.
In addition,
the growing need for more sophisticated drug screening tests to ensure
workplace safety and compliance with regulations is offering a favorable market
outlook.
Apart from
this, the increasing development of advanced screening techniques and
technologies, such as liquid chromatography-mass spectrometry (LC-MS) and
high-performance liquid chromatography (HPLC), is bolstering the growth of the
market.
Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=5624&flag=C
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Product and
Service:
- Equipment
o
Immunoassay Analyzers
o
Chromatography Instruments
o
Breath Analyzers
- Rapid Testing Devices
o
Urine Testing Devices
o
Oral Fluid Testing Devices
- Consumables
o
Assay Kits
o
Sample Collection Cups
o
Calibrators and Controls
o
Others
- Laboratory
Services
Breakup by Sample Type:
- Urine Samples
- Breath Samples
- Oral Fluid Samples
- Hair Samples
- Others
Breakup by End User:
- Hospitals
- Drug Testing Laboratories
- Workplaces
- Drug Treatment Centers
- Pain Management Centers
- Personal Users
- Criminal Justice System and Law
Enforcement Agencies
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
The competitive landscape of the market has been studied in the report with the detailed profiles of the companies operating in the market.
Abbott
Laboratories, Alfa Scientific Designs Inc., Bio-Rad Laboratories Inc.,
Drägerwerk AG & Co. KGaA, Laboratory Corporation of America Holdings,
Lifeloc Technologies Inc., Omega Laboratories Inc., OraSure Technologies Inc.,
Psychemedics Corporation, Quest Diagnostics Incorporated, Siemens AG, Thermo
Fisher Scientific Inc., etc.
About us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
